Trial · NCT02477618
Results by group30
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 30
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
Number of Participants Able to be Weaned Off All Third-Line Agents Prior to End of Double-Blind SAGE-547 or Placebo Infusion, and Remain Off All Third-Line Agents for ≥ 24 Hours Following the End of SAGE-547 or Placebo Infusion | Placebo | 28 | Participants | ||
Number of Participants Able to be Weaned Off All Third-Line Agents Prior to End of Double-Blind SAGE-547 or Placebo Infusion, and Remain Off All Third-Line Agents for ≥ 24 Hours Following the End of SAGE-547 or Placebo Infusion | SAGE-547 | 29 | Participants | ||
| Time Between the Primary Outcome Response and the Re-institution of Any Third-line Agent for Seizure or Burst Suppression | Placebo | 13.500 | Full Range 0.06 to 18.00 | days | |
| Time Between the Primary Outcome Response and the Re-institution of Any Third-line Agent for Seizure or Burst Suppression | SAGE-547 | 14.000 | Full Range 0.18 to 16.00 | days | |
| Number of Participants Able to be Weaned Off All Third-line Agents Before the End of the First SAGE-547 or Placebo Infusion | Placebo | 45 | Participants | ||
| Number of Participants Able to be Weaned Off All Third-line Agents Before the End of the First SAGE-547 or Placebo Infusion | SAGE-547 | 38 | Participants | ||
| Time Between the Secondary Outcome Measure Response and the Re-institution of Any Third-line Agent for Seizure or Burst Suppression | Placebo | 7.000 | Full Range 0.00 to 20.00 | days | |
| Time Between the Secondary Outcome Measure Response and the Re-institution of Any Third-line Agent for Seizure or Burst Suppression | SAGE-547 | 15.000 | Full Range 0.00 to 19.00 | days | |
| Change in Clinical Global Impression Scale (CGI) | Placebo | Baseline | 6.0 | Standard Deviation 0.89 | units on scale |
| Change in Clinical Global Impression Scale (CGI) | SAGE-547 | Baseline | 5.9 | Standard Deviation 1.31 | units on scale |
| Change in Clinical Global Impression Scale (CGI) | Placebo | Visit 12 | -1.0 | Standard Deviation 1.42 | units on scale |
| Change in Clinical Global Impression Scale (CGI) | SAGE-547 | Visit 12 | -0.6 | Standard Deviation 1.91 | units on scale |
| Change in Clinical Global Impression Scale (CGI) | Placebo | Visit 12R | -0.7 | Standard Deviation 1.36 | units on scale |
| Change in Clinical Global Impression Scale (CGI) | SAGE-547 | Visit 12R | -0.5 | Standard Deviation 1.19 | units on scale |
| Number of Days After the End of the First Study Drug Infusion Without Status Epilepticus, Up to Visit 12 | Placebo | Visit 12 | 10.05 | Standard Deviation 6.738 | days |
| Number of Days After the End of the First Study Drug Infusion Without Status Epilepticus, Up to Visit 12 | SAGE-547 | Visit 12 | 11.15 | Standard Deviation 6.058 | days |
| Number of Days After the End of the First Study Drug Infusion Without Status Epilepticus, Up to Visit 12 | Placebo | Visit 12R | 11.08 | Standard Deviation 6.557 | days |
| Number of Days After the End of the First Study Drug Infusion Without Status Epilepticus, Up to Visit 12 | SAGE-547 | Visit 12R | 9.23 | Standard Deviation 6.345 | days |
| Number of Days After the End of the First Study Drug Infusion Without Seizures (Convulsive and Non-convulsive), up to Visit 12 | Placebo | Visit 12 | 8.22 | Standard Deviation 7.289 | days |
| Number of Days After the End of the First Study Drug Infusion Without Seizures (Convulsive and Non-convulsive), up to Visit 12 | SAGE-547 | Visit 12 | 7.50 | Standard Deviation 6.626 | days |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02477618/results